TFPI
Tissue factor pathway inhibitor
Also known as: EPI, LACI, TFI, TFPI1, TFPI1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10646
- Gene
- TFPI
- Ensembl
- ENSG00000003436
- Chromosome
- 2
- Canonical length
- 304 aa
- Protein class
- Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a Kunitz-type serine protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. Inhibition of the encoded protein restores hemostasis in animal models of hemophilia. This gene encodes multiple protein isoforms that differ in their inhibitory activity, specificity and cellular localization. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
304 residues, UniProt reviewed canonical sequence.
>P10646|TFPI
1 MIYTMKKVHA LWASVCLLLN LAPAPLNADS EEDEEHTIIT DTELPPLKLM HSFCAFKADD
61 GPCKAIMKRF FFNIFTRQCE EFIYGGCEGN QNRFESLEEC KKMCTRDNAN RIIKTTLQQE
121 KPDFCFLEED PGICRGYITR YFYNNQTKQC ERFKYGGCLG NMNNFETLEE CKNICEDGPN
181 GFQVDNYGTQ LNAVNNSLTP QSTKVPSLFE FHGPSWCLTP ADRGLCRANE NRFYYNSVIG
241 KCRPFKYSGC GGNENNFTSK QECLRACKKG FIQRISKGGL IKTKRKRKKQ RVKIAYEEIF
301 VKNMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TFPI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 254 nTPM
Expression across tissuesHPA
Tissue
- liver: 254 nTPM
- placenta: 180 nTPM
- lung: 115 nTPM
- adipose tissue: 63 nTPM
- gallbladder: 54 nTPM
- kidney: 53 nTPM
Single-cell type
- extravillous trophoblasts: 3,874 nCPM
- lymphatic endothelial cells: 2,527 nCPM
- syncytiotrophoblasts: 1,286 nCPM
- alveolar cells type 2: 669 nCPM
- hepatocytes: 594 nCPM
- myosatellite cells: 517 nCPM
Immune cell
- basophil: 3.3 nTPM
- plasmacytoid DC: 2.8 nTPM
- total PBMC: 2.7 nTPM
- naive B-cell: 1.5 nTPM
- neutrophil: 1.4 nTPM
- eosinophil: 1 nTPM
Brain region
- choroid plexus: 22 nTPM
- medulla oblongata: 21 nTPM
- cerebellum: 16 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 15 nTPM
- pons: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TFPI.
Disease | AutoantibodyPubMed
Conditions in which antibodies against TFPI are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for TFPI from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Tissue factor pathway and the antiphospholipid syndrome.
2000 · J Autoimmun · RCR 1.5 · 45 citations - High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome.
2003 · J Thromb Haemost · RCR 0.9 · 34 citations - Inflammatory and prothrombotic activation with conserved endothelial function in patients with chronic, asymptomatic Chagas disease.
2011 · Clin Appl Thromb Hemost · RCR 0.9 · 24 citations - Mechanisms of autoantibody-induced monocyte tissue factor expression.
2004 · Thromb Res · RCR 0.7 · 27 citations - The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
2006 · Haematologica · RCR 0.5 · 21 citations
Show 2 more
- Antiphospholipid antibodies and antibodies to tissue factor pathway inhibitor in women with implantation failures or early and late pregnancy losses.
2005 · J Thromb Haemost · RCR 0.4 · 11 citations - Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection-related antiphospholipid antibodies.
2003 · J Thromb Haemost · RCR 0.1 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- cellular response to steroid hormone stimulus
- negative regulation of blood coagulation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pancreatic trypsin inhibitor Kunitz domain
- Tissue factor pathway inhibitor-like
- Proteinase inhibitor I2, Kunitz, conserved site
- Pancreatic trypsin inhibitor Kunitz domain superfamily
- Tissue factor pathway inhibitor/Kunitz-type serine protease inhibitor-like
- Kunitz/Bovine pancreatic trypsin inhibitor domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TFPI as an antibody target. Whether an autoantibody or antibody against TFPI could matter depends on whether native TFPI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TFPI is annotated as secreted, so native TFPI circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TFPI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...